[Skip to Content]
[Skip to Content Landing]
Article
September 1978

Inhibition of Adenovirus Replication in Vitro by Trifluridine

Author Affiliations

From the Department of Microbiology and Immunology, Hahnemann Medical College and Hospital, Philadelphia (Dr Lennette), and the Corneal Service, Wills Eye Hospital, Philadelphia (Dr Eiferman). Dr Eiferman is now with the Department of Ophthalmology, University of Louisville.

Arch Ophthalmol. 1978;96(9):1662-1663. doi:10.1001/archopht.1978.03910060288022
Abstract

• At present, there is no effective chemotherapeutic agent available for the treatment of adenoviral keratoconjunctivitis. Recent evidence suggests that trifluridine (3FT) may effectively inhibit the replication of some adenovirus serotypes known to cause keratoconjunctivitis. The ability of 3FT to inhibit two reference strains of adenoviruses, type 8 and type 19, was examined using cell cultures. Two second-passage isolates of adenoviruses, identified as serotype 13, were also tested. Compared with untreated, virusinfected cell cultures, drug-treated cell cultures developed a lesser degree of cytopathic effect following infection with all three serotypes. Virus production was reduced in the drug-treated cell cultures: approximately tenfold for type 8, more than 1,000-fold for type 19, and 5,000-fold for the type 13 isolates.

×